• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » UK Trade Group Recommends Metrics-Based Approach to Increase Trial Starts

UK Trade Group Recommends Metrics-Based Approach to Increase Trial Starts

October 18, 2021

In an effort to boost the UK’s clinical trial sector, a British pharma industry group has recommended creating a metrics-based national clinical research dashboard to help increase the dwindling number of trials and promote innovative trial designs.

The UK’s methods for reporting clinical research performance are divided and its data collection is not unified, according to the Association of the British Pharmaceutical Industry (ABPI), which recommended the UK set agreed-upon metrics for gauging performance (speed and efficiency, trial volume, quality, innovation and impact) to help track the impact of changes and trends on patients, the National Health Service and the economy.

The number of industry-funded trial starts in the UK has declined over the past five years, according to ABPI, to 440 (excluding COVID studies) in 2020 from 667 in 2017, a 34 percent decrease.

While the UK took the third spot globally (behind the U.S. and Brazil) as the country that initiated the most COVID-19 clinical trials in 2020, it ranked fifth in nonCOVID phase 2 studies globally, launching 201 of them in 2020; the U.S. launched nearly five times that number, 953, in the same year. And for phase 3 trials, the UK ranks just fifth in Europe, behind Germany, Spain, Italy and France, the report showed. It does still lead Europe in phase 1 industry-sponsored trials, though that number has declined.

The ABPI has called on the UK government to create standardized approaches and guidance for sponsors on innovative trial designs and trial delivery, as well as ensuring training is provided to ethics committees, regulators and researchers on such methods. The trade group also called on the country to more readily adopt digital tools that can support remote monitoring and virtual trial components, which were necessitated to keep trials running during the pandemic and are now being used more and more in clinical research.

Read the full report here: https://bit.ly/3mTor2y.

To view more CenterWatch Weekly stories, click here.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing